Related Experiment Video
Updated: Mar 16, 2026
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Therapeutic targets and new directions for antibodies developed for ovarian cancer
Heather J Bax1,2, Debra H Josephs1,2, Giulia Pellizzari1,2
1a St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Center at Guy's and St. Thomas' Hospital and King's College London, Guy's Hospital, King's College London , London , UK.
Abstract:
Antibody therapeutics against different target antigens are widely used in the treatment of different malignancies including ovarian carcinomas, but this disease still requires more effective agents. Improved understanding of the biological features, signaling pathways, and immunological escape mechanisms involved in ovarian cancer has emerged in the past few years. These advances, including an appreciation of the cross-talk between cancer cells and the patient's immune system, have led to the identification of new targets. In turn, potential antibody treatments with various mechanisms of action, including immune activation or toxin-delivery, that are directed at these targets have been developed. Here, we identify established as well as novel targets for antibodies in ovarian cancer, and discuss how they may provide fresh opportunities to identify interventions with enhanced therapeutic potential.
Insights
New antibody targets for ovarian cancer are emerging. Research highlights novel strategies for antibody therapeutics to improve treatment efficacy against this malignancy.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Ovarian cancer treatment relies on antibody therapeutics, yet improved agents are needed.
- Recent advances deepen understanding of ovarian cancer biology, signaling, and immune evasion.
Purpose of the Study:
- To identify established and novel targets for antibody-based therapies in ovarian cancer.
- To explore new intervention opportunities for enhanced therapeutic potential.
Main Methods:
- Literature review and analysis of recent research findings.
- Identification of key biological features, signaling pathways, and immune escape mechanisms.
Main Results:
- Established and novel targets for antibody development in ovarian cancer have been identified.
- Understanding of cancer cell-immune system interactions informs target selection.
Conclusions:
- New targets offer opportunities for developing more effective antibody treatments for ovarian cancer.
- Targeted antibody interventions hold promise for enhanced therapeutic outcomes.
More Related Videos
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
01:27Tumor Immunotherapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:56Treatment Resistant Cancers